Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

FDA Approves Sanofi Pasteur’s Quadracel DTaP-IPV Vaccine for Children

March 25, 2015 12:24 pm | News | Comments

Sanofi Pasteur, the vaccines division of Sanofi announced that FDAhas approved use of Quadracel vaccine for active immunization against diphtheria, tetanus, pertussis and poliomyelitis in children 4 through 6 years of age.

TOPICS:

Report: New Antibiotic Development Remains Weak Despite Incentives

March 25, 2015 12:11 pm | by Andy Szal, Digital Reporter | News | Comments

Regulatory efforts to bolster development of new antibiotic drugs did not result in a stronger drug pipeline, according to a new report from GBI Research.

TOPICS:

Emergent BioSolutions Receives FDA Approval for Anthrasil

March 25, 2015 11:40 am | News | Comments

Emergent BioSolutions has announced that the FDA has approved Anthrasil™ [Anthrax Immune Globulin Intravenous (Human)], also known as AIGIV, for treatment of inhalational anthrax in combination with appropriate antibacterial drugs.

TOPICS:
Advertisement

FDA Approves New Treatment for Diabetic Retinopathy in Patients with Diabetic Macular Edema

March 25, 2015 11:31 am | News | Comments

The FDA has expanded the approved use for Eylea (aflibercept) injection to treat diabetic retinopathy in patients with diabetic macular edema.

TOPICS:

USDA Develops New Poultry Vaccine, Incorporates New Testing Standard

March 25, 2015 8:50 am | by Andy Szal, Digital Reporter | News | Comments

U.S. Agriculture Department scientists recently announced a new vaccine to protect chickens against a pair of potentially fatal diseases.

TOPICS:

AstraZeneca to Collaborate With the Harvard Stem Cell Institute in Diabetes

March 25, 2015 8:45 am | News | Comments

AstraZeneca has entered into a five-year research collaboration with the Harvard Stem Cell Institute (HSCI) to adapt a technique that creates human beta cells from stem cells for use in screens of AstraZeneca’s compound library in the search for new treatments for diabetes.

TOPICS:

Uncertainty About Doctors' Pay Has Taken a Toll on Medicare

March 25, 2015 8:41 am | by RICARDO ALONSO-ZALDIVAR, Associated Press | News | Comments

New momentum for a lasting fix to Medicare's doctor-payment problem shows that lawmakers may finally be recognizing what has long bothered their constituents.

TOPICS:

Modularization Process in Project Delivery

March 25, 2015 8:37 am | by Gene Martini, Design Vice President – IPS | Blogs | Comments

Modularization has been explored and exploited in the delivery of pharmaceutical facilities for many years; the concept can now be considered mature.

TOPICS:
Advertisement

Managing the SUS-Based Facility Design

March 25, 2015 8:31 am | by Jeff Odum, CPIP, IPS-Integrated Project Services, Inc. | Blogs | Comments

There are many nuances that require a more focused approach to risk identification and project management for the “new” manufacturing facilities implementing Single-use Systems (SUS). 

TOPICS:

CDC: Uninsured Drop by 11M Since Passage of Obama's Law

March 25, 2015 8:24 am | by RICARDO ALONSO-ZALDIVAR, Associated Press | News | Comments

The number of uninsured U.S. residents fell by more than 11 million since President Barack Obama signed the health care overhaul five years ago, according to a pair of reports Tuesday from the federal Centers for Disease Control and Prevention.

TOPICS:

Official: Ebola Survivor May Have Infected New Liberia Case

March 25, 2015 8:21 am | by JONATHAN PAYE-LAYLEH, Associated Press | News | Comments

A woman who tested positive for Ebola in Liberia last week is dating a survivor of the disease, a health official said Tuesday, offering a possible explanation for how she became the country's first confirmed case in weeks.

TOPICS:

Justices to Hear Arguments Over EPA Mercury Limits

March 25, 2015 8:18 am | by MARK SHERMAN, Associated Press | News | Comments

The Supreme Court is taking up a challenge by industry groups and Republican-led states that want to roll back Obama administration environmental rules aimed at reducing power plant emissions of mercury and other hazardous air pollutants that contribute to respiratory illnesses, birth defects and developmental problems in children.

TOPICS:

Merck Board OKs Additional $10B Stock Buyback Plan

March 25, 2015 8:15 am | News | Comments

Merck & Co. says its board approved the repurchase of up to $10 billion more of its stock. The company said that amount will be added to the $1.7B remaining available for repurchase under a prior authorization.

TOPICS:

Sun Pharma Announces Closure of Merger Deal with Ranbaxy

March 25, 2015 8:11 am | News | Comments

Sun Pharma today, begins the integration of Ranbaxy's business following the successful closure of its merger.  The integration, planned by Sun Pharma over many months, will focus on supporting strong growth.

TOPICS:

Lycera Announces Milestone in Merck Collaboration

March 25, 2015 8:04 am | News | Comments

Lycera Corp. today announced the achievement of a milestone under the Company's collaboration agreement with Merck, known as MSD outside the United States and Canada, triggering an undisclosed payment.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading